Clinical study of PLA2R epitope spreading for predicting proteinuria remission in primary membranous nephropathy
Compared with CTX, RTX induced a higher rate of immunologic remission at M12. Epitope spreading of PLA2R was identified as an independent risk factor for clinical remission after 6 months of treatment with RTX.
Authors
- Biao Huang (ORCID: https://orcid.org/0000-0002-7315-8779)
- Xue Jing (ORCID: https://orcid.org/0000-0001-6957-1811)
- Xiaobin Liu (ORCID: https://orcid.org/0000-0001-7875-3078)
- Xiran Zhang
- Ting Cai (ORCID: https://orcid.org/0000-0001-7980-3225)
- Caimei Chen (ORCID: https://orcid.org/0000-0003-4954-954X)
- Xinran Cheng (ORCID: https://orcid.org/0000-0003-3543-1559)
- Yi Zhang (ORCID: https://orcid.org/0000-0002-7422-8206)
- Bin Liu (ORCID: https://orcid.org/0000-0003-3477-3178)
- Liang Wang (ORCID: https://orcid.org/0000-0002-1456-4718)
- Zhijian Zhang (ORCID: https://orcid.org/0000-0001-5549-1546)
- Le‐Ting Zhou
- Meiyi Zhou
Institutions
- Zhejiang Sci-Tech University (CN)
- National Health and Family Planning Commission (CN)
- Wuxi People's Hospital (CN)
Publication Details
- Journal
- Frontiers in Immunology
- Published
- 2025-10-22
- DOI
- https://doi.org/10.3389/fimmu.2025.1685738
- Citations
- 1
- Primary Topic
- Renal Diseases and Glomerulopathies
- Type
- article
- Field-Weighted Citation Impact
- 1.43